Human normal/disease tissue samples are reviewed and verified by pathologists through standardized procedures (fixed, frozen, and isolated tissue), and the samples have completeness and reliable data to ensure the advancement of drug development, improve diagnostic accuracy, and accelerate precision medicine research. , can be used for projects in oncology, immunology, and other disease areas.

Features are as follows:

1. Sample credibility: H&E stained images can be viewed in advance, and blocks that meet experimental standards can be quickly identified.

2. Sample data richness: The inventory list includes the donor’s basic clinical data (age, race, gender, resection date, tumor percentage, tumor enrichment area, and key indicators), etc. In addition, the pathology report records the donor’s detailed clinical information.

3. Tissue samples that provide mutation information: Tissue samples are verified using NGS (platforms as follows: Qiagen MultiModal, Illumina TSO500, and Thermo Oncomine Focus) for specific genes in multiple tumor indications and different patients and reviewed by pathologists Therefore, biomarker targets, driver mutations, and clinically significant genomic variants will be more quickly confirmed and identified in the inventory.